43 related articles for article (PubMed ID: 23553333)
1. Single-cell analyses of metastatic bone marrow in human neuroblastoma reveals microenvironmental remodeling and metastatic signature.
Mei S; Alchahin AM; Embaie BT; Gavriliuc IM; Verhoeven BM; Zhao T; Li X; Jeffries NE; Pepich A; Sarkar H; Olsen TK; Wickström M; Stenman J; Reina-Bedoya O; Kharchenko PV; Saylor PJ; Johnsen JI; Sykes DB; Kogner P; Baryawno N
JCI Insight; 2024 Feb; 9(6):. PubMed ID: 38358826
[TBL] [Abstract][Full Text] [Related]
2. A TRANSCRIPTOMIC APPRECIATION OF CHILDHOOD MENINGOCOCCAL AND POLYMICROBIAL SEPSIS FROM A PRO-INFLAMMATORY AND TRAJECTORIAL PERSPECTIVE, A ROLE FOR VASCULAR ENDOTHELIAL GROWTH FACTOR A AND B MODULATION?
Rashid A; Brusletto BS; Al-Obeidat F; Toufiq M; Benakatti G; Brierley J; Malik ZA; Hussain Z; Alkhazaimi H; Sharief J; Kadwa R; Sarpal A; Chaussabe D; Malik RA; Quraishi N; Khilnani P; Zaki SA; Nadeem R; Shaikh G; Al-Dubai A; Hafez W; Hussain A
Shock; 2023 Oct; 60(4):503-516. PubMed ID: 37553892
[TBL] [Abstract][Full Text] [Related]
3. Advancing Clinicopathologic Diagnosis of High-risk Neuroblastoma Using Computerized Image Analysis and Proteomic Profiling.
Niazi MKK; Chung JH; Heaton-Johnson KJ; Martinez D; Castellanos R; Irwin MS; Master SR; Pawel BR; Gurcan MN; Weiser DA
Pediatr Dev Pathol; 2017; 20(5):394-402. PubMed ID: 28420318
[TBL] [Abstract][Full Text] [Related]
4. The Significance of Histopathologic Assessment in Bone Marrow Disease in Neuroblastoma.
Ekmekci S; Ince D; Olgun N; Ozer E
Turk Patoloji Derg; 2022; 38(2):99-105. PubMed ID: 34558657
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of the lncRNA signature associated with overall survival in patients with neuroblastoma.
Yerukala Sathipati S; Sahu D; Huang HC; Lin Y; Ho SY
Sci Rep; 2019 Mar; 9(1):5125. PubMed ID: 30914706
[TBL] [Abstract][Full Text] [Related]
6. Neuroblastoma progression correlates with downregulation of the lymphangiogenesis inhibitor sVEGFR-2.
Becker J; Pavlakovic H; Ludewig F; Wilting F; Weich HA; Albuquerque R; Ambati J; Wilting J
Clin Cancer Res; 2010 Mar; 16(5):1431-41. PubMed ID: 20179233
[TBL] [Abstract][Full Text] [Related]
7. Explorative investigation of vascular endothelial growth factor receptor expression in primary ovarian cancer and its clinical relevance.
Wimberger P; Chebouti I; Kasimir-Bauer S; Lachmann R; Kuhlisch E; Kimmig R; Süleyman E; Kuhlmann JD
Gynecol Oncol; 2014 Jun; 133(3):467-72. PubMed ID: 24713547
[TBL] [Abstract][Full Text] [Related]
8. Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer.
Sopo M; Anttila M; Hämäläinen K; Kivelä A; Ylä-Herttuala S; Kosma VM; Keski-Nisula L; Sallinen H
BMC Cancer; 2019 Jun; 19(1):584. PubMed ID: 31200683
[TBL] [Abstract][Full Text] [Related]
9. CXCR4 expression in neuroblastoma primary tumors is associated with clinical presentation of bone and bone marrow metastases.
Russell HV; Hicks J; Okcu MF; Nuchtern JG
J Pediatr Surg; 2004 Oct; 39(10):1506-11. PubMed ID: 15486895
[TBL] [Abstract][Full Text] [Related]
10. [Vascular endothelial growth factor: its secretion in the bone tissue in the norm and in pathological states].
Kuznetsova OM; Kushlinskiĭ NE; Berezov TT
Biomed Khim; 2003; 49(4):360-73. PubMed ID: 14562681
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel biomarkers in neuroblastoma associated with the risk for bone marrow metastasis: a pilot study.
Osman J; Galli S; Hanafy M; Tang X; Ahmed A
Clin Transl Oncol; 2013 Nov; 15(11):953-8. PubMed ID: 23553333
[TBL] [Abstract][Full Text] [Related]
12. Long-term cultured human neural stem cells undergo spontaneous transformation to tumor-initiating cells.
Wu W; He Q; Li X; Zhang X; Lu A; Ge R; Zhen H; Chang AE; Li Q; Shen L
Int J Biol Sci; 2011; 7(6):892-901. PubMed ID: 21814484
[TBL] [Abstract][Full Text] [Related]
13. Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastoma.
Patterson DM; Gao D; Trahan DN; Johnson BA; Ludwig A; Barbieri E; Chen Z; Diaz-Miron J; Vassilev L; Shohet JM; Kim ES
Angiogenesis; 2011 Sep; 14(3):255-66. PubMed ID: 21484514
[TBL] [Abstract][Full Text] [Related]
14. X-linked inhibitor of apoptosis: a chemoresistance factor or a hollow promise.
Kashkar H
Clin Cancer Res; 2010 Sep; 16(18):4496-502. PubMed ID: 20682709
[TBL] [Abstract][Full Text] [Related]
15. Balance of pro- versus anti-angiogenic splice isoforms of vascular endothelial growth factor as a regulator of neuroblastoma growth.
Peiris-Pagès M; Harper SJ; Bates DO; Ramani P
J Pathol; 2010 Oct; 222(2):138-47. PubMed ID: 20662003
[TBL] [Abstract][Full Text] [Related]
16. Nestin expression in human tumors and tumor cell lines.
Krupkova O; Loja T; Zambo I; Veselska R
Neoplasma; 2010; 57(4):291-8. PubMed ID: 20429619
[TBL] [Abstract][Full Text] [Related]
17. Multiple receptor tyrosine kinases regulate HIF-1alpha and HIF-2alpha in normoxia and hypoxia in neuroblastoma: implications for antiangiogenic mechanisms of multikinase inhibitors.
Nilsson MB; Zage PE; Zeng L; Xu L; Cascone T; Wu HK; Saigal B; Zweidler-McKay PA; Heymach JV
Oncogene; 2010 May; 29(20):2938-49. PubMed ID: 20208561
[TBL] [Abstract][Full Text] [Related]
18. The studies on the correlation for gene expression of tyrosine-kinase receptors and vascular endothelial growth factor in human neuroblastomas.
Zhang J; Zheng Y; Wang Y; Tong H
J Pediatr Hematol Oncol; 2010 Apr; 32(3):180-4. PubMed ID: 20186105
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
